Immuneering Corp (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Immuneering Corp - Ordinary Shares Class A: Is Infosys Ltd. worth buying?
Item: Immuneering Corp - Ordinary Shares Class A
Rating: 1.10666675
Author: Trendlyne DVM scores

about

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

5.14 -0.24 (-4.46%)

49.01% Fall from 52W High

880.4K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Immuneering Corp (Class A) is on 19 May 2026 for the purpose of Immuneering Corp First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

11.2 / 100

Technically Bearish

33.1 / 100

No estimates available

Immuneering Corp (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immuneering Corp (Class A) Live Stock Price Today, Share Analysis and Chart

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

49.01% Fall from 52W High

SWOT Analysis

Immuneering Corp (Class A) Live Price Chart